Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance

American Journal of Human Genetics

Volumn 81, Issue 4, 2007, Pages 799-807

  Milet, Jacqueline ^a,b   Déhais, Valérie ^c   Bourgain, Catherine ^a,b   Jouanolle, Anne Marie ^c   Mosser, Annick ^c   Perrin, Michèle ^c   Morcet, Jeff ^c   Brissot, Pierre ^c   David, Véronique ^c,e   Deugnier, Yves ^c   Mosser, Jean ^a,d,e  

^a INSERM   (France)

^b IFR69   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; FERRITIN; HEMOJUVELIN; HEPCIDIN; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; TRANSFERRIN RECEPTOR 2;

ARTICLE; BONE MORPHOGENETIC PROTEIN 2 GENE; BONE MORPHOGENETIC PROTEIN 4 GENE; FERRITIN BLOOD LEVEL; GENE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HAMP GENE; HEMOCHROMATOSIS; HEMOJUVELIN GENE; HOMOZYGOSITY; IL6 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SLC40A1 GENE; SMAD1 GENE; SMAD4 GENE; SMAD5 GENE;

EID: 35349002878     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/520001     Document Type: Article

References (39)

1. The URLs for data presented herein are as follows:
2. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/ Omim/ (for HFE, HFE3, HFE, TFR2, JH, HJV, HAMP, HFE4, SLC40A1, BMP2, BMP4, SMAD1, SMAD4, SMAD5, IL6, GDF2, BMPR1A, BMPR1B, BMPR2, and STAT3)
3. Schaid Lab Web site, http://mayoresearch.mayo.edu/mayo/research/ schaid_lab/software.cfm?CFIDp7459420&CFTOKEN p67925359 (for haplo.stats software)
4. Loréal O, Haziza-Pigeon C, Troadec MB, Detivaud L, Turlin B, Courselaud B, Ilyin G, Brissot P (2005) Hepcidin in iron metabolism. Curr Protein Pept Sci 6:279-291
5. Brissot P, de Bels F (2006) Current approaches to the management of hemochromatosis. American Society of Hematology, Washington, DC, pp 36-41
6. Pietrangelo A (2005) Non-HFE hemochromatosis. Semin Liver Dis 25:450-460
7. Brissot P, Moirand R, Jouanolle AM, Guyader D, Le Gall JY, Deugnier Y, David V (1999) A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 30:588-593
8. Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830-836
9. Jouanolle AM, Fergelot P, Raoul ML, Gandon G, Roussey M, Deugnier Y, Feingold J, Le Gall JY, David V (1998) Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis? Ann Genet 41:195-198
10. Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154-159
11. Moirand R, Jouanolle AM, Brissot P, Le Gall JY, David V, Deugnier Y (1999) Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 116:372-377
12. Coppin H, Bensaid M, Fruchon S, Borot N, Blanche H, Roth MP (2003) Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians. BMJ 327:132-133
13. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769-1778
14. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845GrA (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-218
15. Deugnier Y, Jouanolle AM, Chaperon J, Moirand R, Pithois C, Meyer JF, Pouchard M, Lafraise B, Brigand A, Caserio-Schoenemann C, et al (2002) Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol 118:1170-1178
16. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718-724
17. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, Edwards CQ, Kushner JP (2000) Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 343:1529-1535
18. Whiting PW, Fletcher LM, Dixon JK, Gochee P, Powell LW, Crawford DH (2002) Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening. J Hepatol 37:309-314
19. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG (2000) Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 66:1246-1258
20. Bensaid M, Fruchon S, Mazeres C, Bahram S, Roth MP, Coppin H (2004) Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 126:1400-1408
21. Livesey KJ, Wimhurst VL, Carter K, Worwood M, Cadet E, Rochette J, Roberts AG, Pointon JJ, Merryweather-Clarke AT, Bassett ML, et al (2004) The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J Med Genet 41:6-10
22. Beutler E, Beutler L, Lee PL, Barton JC (2004) The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol Dis 33:344-345
23. Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Ferec C (2004) The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 13:1913-1918
24. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, et al (2003) Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 12:2241-2247
25. Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C (2004) HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood 103:2835-2840
26. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, et al (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38:531-539
27. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D (2005) Efficiency and power in genetic association studies. Nat Genet 37:1217-1223
28. Barrett JC, Fry B, Maller J, Daly J (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
29. Team RDC (2005) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
30. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95:221-227
31. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
32. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
33. Morris AP, Whittaker JC, Balding DJ (2004) Little loss of information due to unknown phase for fine-scale linkage-disequilibrium mapping with single-nucleotide-polymorphism genotype data. Am J Hum Genet 74:945-953
34. Schaid DJ (2004) Evaluating associations of haplotypes with traits. Genet Epidemiol 27:348-364
35. Clayton D, Chapman J, Cooper J (2004) Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol 27:415-428
36. Custer EM, Finch CA, Sobel RE, Zettner A (1995) Population norms for serum ferritin. J Lab Clin Med 126:88-94
37. Truksa J, Peng H, Lee P, Beutler E (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci USA 103:10289-10293
38. Wrighting DM, Andrews NC (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108:3204-3209
39. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109:353-358